Coursera Valuation
Is COUR * undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
2/6Valuation Score 2/6
Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of COUR * when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: COUR * (MX$332) is trading below our estimate of fair value (MX$432.78)
Significantly Below Fair Value: COUR * is trading below fair value by more than 20%.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for COUR *?
Other financial metrics that can be useful for relative valuation.
What is COUR *'s n/a Ratio? | |
---|---|
n/a | 0x |
n/a | n/a |
Market Cap | US$1.88b |
Key Statistics | |
---|---|
Enterprise Value/Revenue | 1.8x |
Enterprise Value/EBITDA | -8.3x |
PEG Ratio | n/a |
Price to Sales Ratio vs Peers
How does COUR *'s PS Ratio compare to its peers?
Company | Forward PS | Estimated Growth | Market Cap |
---|---|---|---|
Peer Average | 1.8x | ||
ALSEA * Alsea. de | 0.6x | 9.1% | Mex$43.1b |
RLH A RLH Properties. de | 2.5x | n/a | Mex$18.4b |
POSADAS A Grupo Posadas. de | 1.5x | n/a | Mex$13.5b |
AFYA Afya | 2.7x | 9.9% | US$1.5b |
COUR * Coursera | 3x | 14.0% | Mex$1.9b |
Price-To-Sales vs Peers: COUR * is expensive based on its Price-To-Sales Ratio (3x) compared to the peer average (1.6x).
Price to Earnings Ratio vs Industry
How does COUR *'s PE Ratio compare vs other companies in the Global Consumer Services Industry?
Price-To-Sales vs Industry: COUR * is expensive based on its Price-To-Sales Ratio (3x) compared to the Global Consumer Services industry average (1.3x).
Price to Sales Ratio vs Fair Ratio
What is COUR *'s PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
Fair Ratio | |
---|---|
Current PS Ratio | 3x |
Fair PS Ratio | n/a |
Price-To-Sales vs Fair Ratio: Insufficient data to calculate COUR *'s Price-To-Sales Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Insufficient data to show price forecast.